Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Rectal Neoplasms 1Breast Neoplasms 1Anus Neoplasms 1

Interventions

Brachytherapy 2trastuzumab deruxtecan 1liposomal doxorubicin 1entinostat 1dostarlimab 1bintrafusp alfa protein, human 1Therapeutic Touch 1Surveys and Questionnaires 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Platinum 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Doxorubicin 1Dehydroepiandrosterone 1Congresses as Topic 1Cisplatin 1Bupropion 1Bevacizumab 1Axitinib 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vaginal Neoplasms × Dehydroepiandrosterone × 90 days × Clear all
NCT07407647 2026-04-21

Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
25 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡